Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Sussman

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Artificial Organs|January 1, 1993
Improved liver function following treatment with an extracorporeal liver assist deviceN L Sussman, J H Kelly
Artificial Organs|January 1, 1993
Liver assist devices (LADs) will not be used to treat fulminant hepatic failure (FHF), but its consequences, namely hepatic encephalopathy (HE)N L Sussman, J H Kelly
Blood Purification|January 1, 1993
Extracorporeal liver assist in the treatment of fulminant hepatic failureN L Sussman, J H Kelly
Hepatology (Baltimore, Md.)|June 1, 1993
Artificial liver: a forthcoming attractionN L Sussman, J H Kelly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1996
Treatment of hepatic failure--1996: current concepts and progress toward liver dialysisN L Sussman, J R Lake
Journal of Biomolecular Screening|September 19, 2000
A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibitionJ H Kelly, N L Sussman
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1996
Artificial liver supportN L Sussman, J H Kelly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 31, 1997
Extracorporeal liver support: cell-based therapy for the failing liverN L Sussman, J H Kelly
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1994
The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failureJ H Kelly, N L Sussman
Hepatology (Baltimore, Md.)|March 1, 1995
Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answerJ R Lake, N L Sussman
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Artificial Organs|January 1, 1993
Improved liver function following treatment with an extracorporeal liver assist deviceN L Sussman, J H Kelly
Artificial Organs|January 1, 1993
Liver assist devices (LADs) will not be used to treat fulminant hepatic failure (FHF), but its consequences, namely hepatic encephalopathy (HE)N L Sussman, J H Kelly
Blood Purification|January 1, 1993
Extracorporeal liver assist in the treatment of fulminant hepatic failureN L Sussman, J H Kelly
Hepatology (Baltimore, Md.)|June 1, 1993
Artificial liver: a forthcoming attractionN L Sussman, J H Kelly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1996
Treatment of hepatic failure--1996: current concepts and progress toward liver dialysisN L Sussman, J R Lake
Journal of Biomolecular Screening|September 19, 2000
A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibitionJ H Kelly, N L Sussman
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1996
Artificial liver supportN L Sussman, J H Kelly
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 31, 1997
Extracorporeal liver support: cell-based therapy for the failing liverN L Sussman, J H Kelly
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 1, 1994
The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failureJ H Kelly, N L Sussman
Hepatology (Baltimore, Md.)|March 1, 1995
Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answerJ R Lake, N L Sussman
Pageof 3